Source: Annual Congress 2003 - Epidemiological aspects of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Lawrence, I. K. Taylor, N. P. Keaney (Sunderland, United Kingdom). Pre- and post- bronchodilator FEV₁ does not perturb a multidimensional system (IDS) for categorising the clinical impact of COPD: comparison of ERS, BTS and GOLD guidelines. Eur Respir J 2003; 22: Suppl. 45, 1453

Member's Comments

No comment yet.

Related content which might interest you: The current ERS, BTS, ATS and GOLD classification criteria underestimate the impact of COPD on patients Source: Eur Respir J 2002; 20: Suppl. 38, 254s Year: 2002 The effect of adopting new GLI-2012 spirometric reference values on airflow limitation GOLD classification Source: International Congress 2015 – Lung function: waiting to exhale... Year: 2015 Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 The effects of standard therapy for COPD patients on FEV1 are associated with lower score of the Goddard classification Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Does measuring pre or post bronchodilator FEV1 influence the level of asthma control in patients with controlled or partially controlled asthma as measured by GINA scale? Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 GOLD assessment of COPD patients: Impact of symptoms assessment choice Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014 Combined COPD assessment using the new GOLD guidelines Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 The prevalence of patients with normal post-bronchodilator spirometry that fulfil the criteria for GOLD mild COPD using ECCS predicted equations Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019 Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1 Source: Eur Respir J 2004; 23: 497-498 Year: 2004 Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Development and validation of an innovative self-administered computerized (SAC) version of baseline/transition dyspnea index (BDI/TDI) for evaluating breathlessness in patients with COPD: The BLAZE study Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 CAT’ or ’mMRC’ – Which is a better symptom scale in recent GOLD COPD classification? Source: International Congress 2015 – COPD: interesting notes Year: 2015 Glycopyrronium (GLY) and tiotropium (TIO) comparison: Lung function, dyspnea and health status in COPD patients in all GOLD groups Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Concordance among GOLD, NICE and LLN criteria in the spirometry diagnosis of airflow obstruction Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Impulse oscillometry assessment of small airway dysfunction pre- and post-bronchodilator in asthma and its relationship to disease severity Source: International Congress 2014 – Alterations of exercise and lung function in different diseases Year: 2014 Physiologic study of patients with COPD: Respiratory mechanics according to staging of GOLD and BODE index Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010